Zymeworks Inc. (ZYME)

NASDAQ: ZYME · USD

$28.9

+0.01 (+0.0%)· Recorded snapshot

Market cap	2B
Revenue (ttm)	37.1M
Net income (ttm)	-150M
EPS (ttm)	-$2.01
Shares out	71M
P/E (forward)	14.3x
Volume	716,748
Beta	1.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 37.1M
Net income (ttm): -150M
EPS (ttm): -$2.01
P/E (forward): 14.3x
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E14.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-72.3

P25 n/aP50 n/aP75 n/a

ROIC-97.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ZYME indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001937653
Company name	Zymeworks Inc.
Country	United States
Country code	US
CUSIP number	98985Y108
Earnings date	2026-11-09
Earnings time	amc
Employees	231
Employees change	-42
Employees growth	-15.38%
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2017-04-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US98985Y1082
Last 10-K release date	2026-03-02
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$28.86
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ZYME
U.S. state	Delaware
Website	https://www.zymeworks.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-6.97%
EV/Sales	47.19x
FCF / EV yield	-6.88%
FCF yield	-5.86%
Forward EV/Sales	3.99x
Forward P/E	14.27x
Forward P/S	4.69x
P/B ratio	25.63x
P/S ratio	55.45x
Price / tangible book value	30.56x
Sector forward P/E	23.65x
Sector P/E	50.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-246.66%
Operating margin	-418.99%
Pretax margin	-407.76%
Profit per employee	$-649,316
Revenue per employee	$160,723
ROA	-24.14%
ROA (5Y)	-11.23%
ROCE	-44.48%
ROE	-72.31%
ROE (5Y)	-22.56%
ROIC	-97.68%
ROIC (5Y)	-402.4%
SBC / revenue	91.66%
Tax / revenue	-3.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Net income growth years	1
Revenue growth	-69.78%
Revenue growth (Q)	-90.58%
Revenue growth (QoQ)	90.61%
Revenue growth 10Y	14.41%
Revenue growth 3Y	-56.39%
Revenue growth 5Y	12.35%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.2M
Depreciation and amortization	$4.9M
EBIT	$-155.6M
EBITDA	$-150.7M
EPS	$-2.01
FCF per share	$-1.70
Financing cash flow	$107.6M
Free cash flow	$-120.5M
Free cash flow minus SBC	$-154.6M
Gross profit	$-91.6M
Income taxes	$-1.4M
Investing cash flow	$92.8M
Net cash flow	$81.2M
Net income	$-150M
Operating cash flow minus SBC	$-153.4M
Operating income	$-155.6M
Revenue	$37.1M
Stock-based compensation	$34M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.58
Book value per share	$1.13
Debt / equity	0.2
Goodwill	$12M
Interest coverage	-17.96
Long-term assets	$98.6M
Long-term liabilities	$269.4M
Net cash (debt)	$306.5M
Net cash / market cap	14.89%
Net cash growth	-2.61%
Net debt / equity	-3.81
Piotroski F-Score	1
Property, plant and equipment	$27.2M
Shareholders' equity	$80.4M
Tangible book value	$67.4M
Tangible book value per share	$0.94
Total assets	$397M
Total cash	$270.7M
Total debt	$16M
Total liabilities	$316.6M
WACC	10.95%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.09
Current assets	$298.4M
Current liabilities	$47.2M
Current ratio	6.32
Net working capital	$-16.3M
Quick ratio	5.86
Working capital	$251.1M
Working capital turnover	0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.84%
Dividend yield	0%
Shareholder yield	0.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$25.74
1D price change	0.03%
1M price change	9.16%
1M total return	9.16%
1W price change	7.58%
1W total return	7.58%
1Y price change	56.74%
1Y return CAGR	56.79%
1Y total return	56.74%
20-day SMA	$26.50
200-day SMA	$25.18
3M price change	25.87%
3M total return	25.87%
3Y price change	335.34%
3Y return CAGR	63.27%
3Y total return	335.34%
50-day SMA	$27.23
50-day SMA vs 200-day SMA	50over200
52-week high	$31.34
52-week high date	2026-09-03
52-week low	$16.00
52-week low date	2025-11-07
5Y price change	27.76%
5Y return CAGR	5.02%
5Y total return	27.76%
6M price change	1.37%
6M total return	1.37%
All-time high	$59.03
All-time high date	2021-01-12
All-time low	$4.11
All-time low date	2022-09-07
Average true range (ATR)	$1.16
Average volume	1.3M
Beta (1Y)	0.31
Beta (2Y)	0.96
Beta (5Y)	1.17
Change from 52-week high	-7.91%
Change from 52-week low	80.34%
Change from all-time high	-50.96%
Change from all-time low	604.38%
Change from open	0.03%
Day's gap	0%
Dollar volume	$20.7M
High price	$29.43
Low price	$28.79
Monthly RSI	63.3
Open price	$28.85
Position in 52-week range	10.94%
Premarket change	-0.21%
Premarket close	$28.85
Premarket price	$28.79
Previous close	$28.85
Price vs 150-day SMA	12.47%
Price vs 20-day SMA	9.27%
Price vs 200-day SMA	14.98%
Price vs 50-day SMA	6.31%
Relative volume	0.56
RSI	62.96
Sharpe ratio	1.01
Sharpe ratio (3Y)	1.12
Sharpe ratio (5Y)	0.31
Sortino ratio	1.91
Sortino ratio (3Y)	1.96
Sortino ratio (5Y)	0.56
Volume	716.7K
Weekly RSI	60.14
YTD price change	9.95%
YTD total return	9.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65.8M
Float percentage	92.75%
Shares change (QoQ)	-2.28%
Shares change (YoY)	-0.84%
Shares held by insiders	1.35%
Shares held by institutions	45.45%
Shares outstanding	71M
Short % of float	8.04%
Short % of shares	7.46%
Short ratio	6.6 days

Deeper analysis on ZYME

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ZYME report

Is a complete ZYME research report available?

No complete published report is available for Zymeworks Inc. (ZYME) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Zymeworks Inc. (ZYME)

Price

Financial snapshot

Fair-value bridge

Latest news · ZYME

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZYME indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ZYME

Frequently asked questions